Conditions of radioiodination with iodogen as oxidizing agent.

Conditions of radioiodination with iodogen as oxidizing agent. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Conditions of radioiodination with iodogen as oxidizing agent. Abstract Text:

G B Saha,J Whitten,R T Go,

Different factors that give the maximum iodination of proteins by iodogen method have been evaluated. The quantity of iodogen was varied from 2 to 20 micrograms; pH from 3 to 9; the quantity of bovine serum albumin (BSA) from 25 micrograms to 2 mg; the 131I activity from 200 microCi to 5 mCi and the reaction time from 2 to 30 min. The maximum iodination of proteins is achieved with iodogen-to-iodide molar ratio of 100-200 and iodogen-to-protein molar ratio of 1-2 at pH 6-8 for 10-15 min at room temperature.

Conditions of radioiodination with iodogen as oxidizing agent. Publishing Authors By Initials

GB Saha,J Whitten,RT Go,

For similar organic chemicals: urea research abstracts see: organic chemicals: urea research

PUBMED ID PMID:

MEDLINE DATE:

Conditions of radioiodination with iodogen as oxidizing agent. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: International journal of radiation applications an

VOLUME: 16

Page Numbers: 431-3

Journal Abbreviation:

ISSN: 0883-2897

DAY: 21

MONTH: 02

YEAR: 1989

Conditions of radioiodination with iodogen as oxidizing agent. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8611098

Conditions of radioiodination with iodogen as oxidizing agent. Keywords Mesh Terms:

KEYWORDS: Urea

MESH TERMS: analogs & derivatives

Chemical & Substance for Abstract: Conditions of radioiodination with iodogen as oxidizing agent. Information

Substance Name: Urea

Registry Number: 57-13-6

Grant and Affiliation Information for Conditions of radioiodination with iodogen as oxidizing agent.

AFFILIATION: Department of Nuclear Medicine, Cleveland Clinic Foundation, OH 44195-5074.

Country: UNITED STATES

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Int J Rad Appl Instrum B

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Conditions of radioiodination with iodogen as oxidizing agent Related Publications

• A Cross-Sectional Study on Prevalence of Non-Fatal Drug Overdose and Associated Risk Characteristics Among Out-of-Treatment Injecting Drug Users in North Vietnam.
• A polymorphism in SOD2 is associated with development of Alzheimer's disease.
• Antiproliferative activity of chalcones with basic functionalities.
• Are there susceptible hosts to Helicobacter pylori infection?
• Association studies of transforming growth factor-beta 1 and Alzheimer's disease.
• Cerebral perfusion and vascular reserve in fibromuscular dysplasia of the internal carotid artery.
• Chryseobacterium soli sp. nov. and Chryseobacterium jejuense sp. nov., isolated from soil samples from Jeju, Korea.
• Community-based incidence of acute renal failure.
• Comparison of high- versus low-tissue affinity ACE-inhibitor treatment on circulating aldosterone levels in patients with chronic heart failure.
• Comparison of normal mode analyses on a small globular protein in dihedral angle space and Cartesian coordinate space.
• Conditions of radioiodination with iodogen as oxidizing agent.
• Conversion of the coenzyme specificity of isocitrate dehydrogenase by module replacement.
• Correlation between pulse wave velocity and other measures of arterial stiffness in chronic kidney disease.
• Determination of Body Fat Distribution by Dual-Energy X-ray Absorptiometry and Attenuation of Visceral Fat Vasoconstriction by Enalapril.
• Effects of chronic stress and interleukin-10 gene polymorphisms on antibody response to tetanus vaccine in family caregivers of patients with Alzheimer's disease.
• Exudation and absorption mechanisms of the normal conjunctival capillaries.
• Follow-up mapping supports the evidence for linkage in the candidate region at 9q22 in the NIMH Alzheimer's disease Genetics Initiative cohort.
• Functionalized chalcones as selective inhibitors of P-glycoprotein and breast cancer resistance protein.
• Further studies on the interaction of protein kinase C with phospholipid, diacylglycerol, and phorbol ester.
• Genetic Association of Neurotrophic Tyrosine Kinase Receptor Type 2 (NTRK2) With Alzheimer's Disease.
• Het-PDB Navi.: a database for protein-small molecule interactions.
• MRI of cranial nerve enhancement.
• Matrix metalloproteinase circulating levels, genetic polymorphisms, and susceptibility to acute myocardial infarction among patients with coronary artery disease.
• Minutes of the business meeting of the american pancreatic association thursday, november 2, 2006, chicago, illinois.
• Polymorphisms in hypoxia inducible factor 1 and the initial clinical presentation of coronary disease.
• Quantitative structure-activity relationship (QSAR) of indoloacetamides as inhibitors of human isoprenylcysteine carboxyl methyltransferase.
• Risks for end-stage renal disease, cardiovascular events, and death in Hispanic versus non-Hispanic white adults with chronic kidney disease.
• Role of tumor markers in the management of primary intracranial germ cell tumors.
• Roseomonas aerilata sp. nov., isolated from an air sample.
• The conformation of alpha-human atrial natriuretic polypeptide in solution.